Therapeutic Asset Ratings
159 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
DARATUMUMAB
Non Hodgkin Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
B
(59)
DEXAMETHASONE
Metastatic Prostate Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(58)
TACROLIMUS
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P4
B
(57)
FILGRASTIM
Dyskeratosis Congenita
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(57)
Olaparib
Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(57)
TACROLIMUS
Immune Deficiency Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(57)
TESTOSTERONE UNDECYLATE
Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(57)
Pamiparib
Recurrent WHO Grade II Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
B
(57)
Pamiparib
Recurrent WHO Grade III Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
B
(57)
Senaparib
Primary Peritoneal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(55)
TESTOSTERONE CIPIONATE
Metastatic Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(55)
HUMANIZED, DUAL-AFFINITY RE-TARGETING, OR (DART), MOLECULE THAT RECOGNIZES BOTH CD123 AND CD3
AML
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(54)
(-)-SIRPIGLENASTAT
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CCC
(54)
Cyclophosphamide
Congenital Immunodeficiency
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Cyclophosphamide
Dyskeratosis Congenita
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Cyclophosphamide
Hoyeraal-Hreidarsson Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Cyclophosphamide
Non Fanconi DNA-DSB Repair Disorder
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Cyclophosphamide
Primary Immune Deficiency Disorder
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Cyclophosphamide
Short Telomere Length
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Cyclophosphamide
Telomere Biology Disorder
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Dalmitamig
Colo-rectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Evomela
Dyskeratosis Congenita
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Evomela
Hoyeraal-Hreidarsson Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Evomela
Non Fanconi DNA-DSB Repair Disorder
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Evomela
Short Telomere Length
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(53)
Showing 26 to 50 of 159 assets
Previous
Page 2 of 7
Next